These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

598 related items for PubMed ID: 17375639

  • 1. Low dose transtympanic gentamicin treatment for intractable Meniere's disease: a prospective study.
    Kasemsuwan L, Jariengprasert C, Ruencharopen S, Orathai P.
    J Med Assoc Thai; 2007 Feb; 90(2):327-34. PubMed ID: 17375639
    [Abstract] [Full Text] [Related]

  • 2. Transtympanic gentamicin treatment in Meniere's disease: a preliminary report.
    Kasemsuwan L, Jariengprasert C, Chaturapatranont S.
    J Med Assoc Thai; 2006 Jul; 89(7):979-85. PubMed ID: 16881430
    [Abstract] [Full Text] [Related]

  • 3. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N, Martín E, García-Tapia R.
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [Abstract] [Full Text] [Related]

  • 4. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC, Minor LB.
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [Abstract] [Full Text] [Related]

  • 5. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF, Poe DS.
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [Abstract] [Full Text] [Related]

  • 6. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
    Hillman TA, Chen DA, Arriaga MA.
    Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
    [Abstract] [Full Text] [Related]

  • 7. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H, Wazen J, Van Ess MJ, Daugherty J, Alameda YA.
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [Abstract] [Full Text] [Related]

  • 8. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
    Casani A, Nuti D, Franceschini SS, Gaudini E, Dallan I.
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516
    [Abstract] [Full Text] [Related]

  • 9. Transtympanic steroids for Ménière's disease.
    Herraiz C, Plaza G, Aparicio JM, Gallego I, Marcos S, Ruiz C.
    Otol Neurotol; 2010 Jan; 31(1):162-7. PubMed ID: 19924013
    [Abstract] [Full Text] [Related]

  • 10. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V, Carner M, Colletti L.
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [Abstract] [Full Text] [Related]

  • 11. [Long-term results of transtympanic gentamicin treatment in Meniere's disease].
    Pierchała K, Krzeska-Malinowska I, Kowalska M, Bartoszewicz R, Niemczyk K.
    Otolaryngol Pol; 2005 Feb; 59(3):409-13. PubMed ID: 16117399
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intratympanic gentamicin instillation as treatment of unilateral Menière's disease: update of an ongoing study.
    Nedzelski JM, Chiong CM, Fradet G, Schessel DA, Bryce GE, Pfleiderer AG.
    Am J Otol; 1993 May; 14(3):278-82. PubMed ID: 8372926
    [Abstract] [Full Text] [Related]

  • 14. Transtympanic gentamicin treatment using Silverstein MicroWick in Ménière's disease patients: long term outcome.
    Suryanarayanan R, Srinivasan VR, O'Sullivan G.
    J Laryngol Otol; 2009 Jan; 123(1):45-9. PubMed ID: 18533050
    [Abstract] [Full Text] [Related]

  • 15. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
    Perez N, Boleas MS, Martin E.
    Audiol Neurootol; 2005 Jan; 10(2):69-78. PubMed ID: 15650298
    [Abstract] [Full Text] [Related]

  • 16. Intratympanic gentamicin for the treatment of unilateral Meniere's disease.
    Kaplan DM, Nedzelski JM, Chen JM, Shipp DB.
    Laryngoscope; 2000 Aug; 110(8):1298-305. PubMed ID: 10942130
    [Abstract] [Full Text] [Related]

  • 17. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A, Saika T, Uno A, Nishiike S, Mitani K, Nishimura M, Kitahara T, Fukushima M, Nakagawa A, Masumura C, Sasaki T, Kizawa K, Kubo T.
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [Abstract] [Full Text] [Related]

  • 18. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ, Fisher LM, Berliner K, Chung J, Green K.
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Middle ear exploration in patients with Ménière's disease who have failed outpatient intratympanic gentamicin therapy.
    Crane BT, Minor LB, Della Santina CC, Carey JP.
    Otol Neurotol; 2009 Aug; 30(5):619-24. PubMed ID: 19503016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.